UCPMP (Syllabus: GS Paper 2 – Health)

Context: The Central Government recently rolled out a Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for pharmaceutical companies.

Uniform Code for Pharmaceutical Marketing Practices (UCPMP)

• Implementation: UCPMP 2024 aims to regulate unethical practices within the pharmaceutical industry.
• Updated Guidelines: The guidelines cover areas such as drug endorsement, promotion, ethical conduct for medical representatives, and interactions with healthcare professionals.
• Important Provisions:
• Prohibition of Gifts and Travel Facilities: Pharma companies are barred from offering gifts or travel facilities to healthcare professionals or their families.
• Ethical Conduct for Medical Representatives: Medical representatives are prohibited from using inducements or subterfuge to gain access to healthcare professionals.
• Company Accountability: Pharma companies are held responsible for the actions of their medical representatives.
• Ban on Free Samples Distribution: Free samples cannot be provided to individuals unqualified to prescribe the product.
• Establishment of Ethics Committee: Pharmaceutical associations must form an Ethics Committee and a dedicated UCPMP portal on their websites.
• Guidelines for Drug Promotion: Specific rules outline how drugs can be promoted, emphasizing balance, accuracy, and non-misleading information.
• Penalties and Complaint Handling: Detailed penalties for violations are specified, and complaints are addressed by the Ethics Committee for Pharmaceutical Marketing Practices (ECPMP).